Organization
Dren Bio
3 clinical trials
Clinical trial
A Multicenter, Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Multiple Ascending Doses in Patients With Relapsed/Refractory B Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Multicenter, Open-Label, First-In-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A First-in-Human Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Single Ascending Dose in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-06-01